Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey S. Hatfield currently holds 16,000 shares of Vir Biotechnology, Inc. (VIR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey S. Hatfield has been a net seller of VIR stock. They have purchased $0 and sold $1.4M worth of shares.
Jeffrey S. Hatfield's most recent insider trade was on May 27, 2026, when they sold 16,000 shares at $0.00 per share.
Jeffrey S. Hatfield serves as Executive at Vir Biotechnology, Inc. (VIR). They have executed 19 insider transactions totaling $1.4M over their tenure at the company.
Jeffrey S. Hatfield holds the position of Executive at Vir Biotechnology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Jeffrey S. Hatfield has shown a selling trading pattern, with $0 in total purchases and $1.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jeffrey S. Hatfield was on Oct 24, 2016, when they sold $5.1M worth of VTAE shares. This transaction involved 244,996 shares at $21.00 per share.
Jeffrey S. Hatfield currently owns 16,000 shares of Vir Biotechnology, Inc. (VIR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey S. Hatfield's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey S. Hatfield has 19 Form 4 filings on record as an insider at Vir Biotechnology, Inc..
Set alerts for Jeffrey S. Hatfield and 40,000+ other insiders.